| Pitfalls in the measurement of muscle mass: a need for a reference standard |
90 |
| Skeletal muscle performance and ageing |
83 |
| Sarcopenia: A Time for Action. An SCWD Position Paper |
56 |
| Sarcopenia and its association with falls and fractures in older adults: A systematic review and meta-analysis |
54 |
| GLIM criteria for the diagnosis of malnutrition - A consensus report from the global clinical nutrition community |
52 |
| Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer |
30 |
| D-3-Creatine dilution and the importance of accuracy in the assessment of skeletal muscle mass |
30 |
| Cachexia induced by cancer and chemotherapy yield distinct perturbations to energy metabolism |
29 |
| miRNA-23a/27a attenuates muscle atrophy and renal fibrosis through muscle-kidney crosstalk |
27 |
| A newly identified lncRNA MAR1 acts as a miR-487b sponge to promote skeletal muscle differentiation and regeneration |
25 |
| LncIRS1 controls muscle atrophy via sponging miR-15 family to activate IGF1-PI3K/AKT pathway |
24 |
| Circulating myomiRs: a new class of biomarkers to monitor skeletal muscle in physiology and medicine |
23 |
| Effectiveness of a multimodal intervention in functionally impaired older people with type 2 diabetes mellitus |
22 |
| Associations of pre-existing co-morbidities with skeletal muscle mass and radiodensity in patients with non-metastatic colorectal cancer |
21 |
| Fibroblast growth factor 21 controls mitophagy and muscle mass |
21 |
| Sarcopenia as a comorbidity-independent predictor of survival following radical cystectomy for bladder cancer |
21 |
| Repeatability of Dixon magnetic resonance imaging and magnetic resonance spectroscopy for quantitative muscle fat assessments in the thigh |
21 |
| miR-424-5p reduces ribosomal RNA and protein synthesis in muscle wasting |
20 |
| Protein imbalance in the development of skeletal muscle wasting in tumour-bearing mice |
20 |
| Cell therapy to improve regeneration of skeletal muscle injuries |
20 |
| The relationship between computed tomography-derived body composition, systemic inflammatory response, and survival in patients undergoing surgery for colorectal cancer |
19 |
| Treating cachexia using soluble ACVR2B improves survival, alters mTOR localization, and attenuates liver and spleen responses |
18 |
| Reference values for handgrip strength and their association with intrinsic capacity domains among older adults |
17 |
| Prevalence of rheumatoid cachexia in rheumatoid arthritis: a systematic review and meta-analysis |
17 |
| Circulating miR-203 derived from metastatic tissues promotes myopenia in colorectal cancer patients |
17 |
| Low-protein diet for conservative management of chronic kidney disease: a systematic review and meta-analysis of controlled trials |
17 |
| Computed tomography diagnosed cachexia and sarcopenia in 725 oncology patients: is nutritional screening capturing hidden malnutrition? |
17 |
| Short-term disuse promotes fatty acid infiltration into skeletal muscle |
17 |
| Preoperative sarcopenia and post-operative accelerated muscle loss negatively impact survival after resection of pancreatic cancer |
17 |
| Determinants of muscle preservation in individuals with cerebral palsy across the lifespan: a narrative review of the literature |
16 |
| Poor performance of psoas muscle index for identification of patients with higher waitlist mortality risk in cirrhosis |
16 |
| Alterations in the in vitro and in vivo regulation of muscle regeneration in healthy ageing and the influence of sarcopenia |
16 |
| Sarcopenia is negatively associated with long-term outcomes in locally advanced rectal cancer |
16 |
| Protein supplementation improves lean body mass in physically active older adults: a randomized placebo-controlled trial |
16 |
| Impact of sarcopenia on prognostic value of cirrhosis: going beyond the hepatic venous pressure gradient and MELD score |
16 |
| Circulating factors associated with sarcopenia during ageing and after intensive lifestyle intervention |
15 |
| Physical activity unveils the relationship between mitochondrial energetics, muscle quality, and physical function in older adults |
15 |
| Association between body composition, survival, and toxicity in advanced esophagogastric cancer patients receiving palliative chemotherapy |
15 |
| Healthy community-living older men differ from women in associations between myostatin levels and skeletal muscle mass |
15 |
| Systematic review and meta-analysis of cannabinoids in palliative medicine |
14 |
| Sedentary behaviour, physical activity, and sarcopenia among older adults in the TSHA: isotemporal substitution model |
14 |
| Introducing the 'Drucebo' effect in statin therapy: a systematic review of studies comparing reported rates of statin-associated muscle symptoms, under blinded and open-label conditions |
14 |
| The deterioration of muscle mass and radiodensity is prognostic of poor survival in stage I-III colorectal cancer: a population-based cohort study (C-SCANS) |
14 |
| Tracking disease progression non-invasively in Duchenne and Becker muscular dystrophies |
14 |
| Myricanol rescues dexamethasone-induced muscle dysfunction via a sirtuin 1-dependent mechanism |
14 |
| MyD88 signalling is critical in the development of pancreatic cancer cachexia |
13 |
| Iron deficiency as energetic insult to skeletal muscle in chronic diseases |
13 |
| LY249 an antimyostatin antibody, in pancreatic cancer: a randomized, phase 2 trial |
13 |
| Impact of different palliative systemic treatments on skeletal muscle mass in metastatic colorectal cancer patients |
13 |
| RAGE in the pathophysiology of skeletal muscle |
13 |
